Designing of heterocyclic compounds as promising VEGFR2 tyrosine kinase inhibitors: An Insilico analysis. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 13, n. 6, p. 685–698, 2021. DOI: 10.25004/IJPSDR.2021.130612. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/3703.. Acesso em: 16 oct. 2025.